Yan Lu
About Yan Lu
Yan Lu is the Associate Director Of Strategy at BeiGene in Beijing, China, with extensive experience in strategy and investor relations within the pharmaceutical industry.
Company
Yan Lu is currently employed at BeiGene in Beijing, China. BeiGene is a globally recognized biotechnology company focused on developing innovative oncology treatments. As part of the company's strategy team, Yan has contributed to BeiGene's market positioning and growth.
Title
Yan Lu holds the position of Associate Director of Strategy at BeiGene. In this role, Yan plays a pivotal part in shaping the strategic direction of the company, leveraging extensive experience in strategic management and investor relations within the pharmaceutical industry.
Education and Expertise
Yan Lu's educational background includes a Doctor of Philosophy (Ph.D.) in Pharmacy from the University of Manitoba, completed between 2010 and 2016. Additionally, Yan studied at Qingdao Agricultural University, earning a Bachelor's Degree in Food Science and Engineering from 2006 to 2010. In 2014, Yan completed the Foundation of Project Management course at Mitacs, further enhancing project management skills. Yan's expertise spans strategic management, investor relations, pharmacy, and food science.
Background
Yan Lu has extensive experience in both scientific research and strategic roles. At BeiGene, Yan progressed from Manager of Strategy and Investor Relations to Sr. Manager of Strategy, before assuming the current role of Associate Director of Strategy. Previous roles include Investor Relations Manager at Sihuan Pharmaceutical Co., Ltd and various research positions at St-Boniface Hospital Research in Canada. This diverse background bridges technical and business aspects in the pharmaceutical sector.
Achievements
Throughout Yan Lu's career, significant contributions were made to strategic initiatives that aided BeiGene's market growth. These roles capitalized on Yan's ability to integrate scientific research with strategic business management, benefiting the company's positioning in the pharmaceutical industry. Yan's work in both Chinese and Canadian healthcare sectors brings a valuable international perspective to the table.